ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
24
views
0
references
Top references
cited by
15
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,529
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: A randomized placebo-controlled trial
Author(s):
Gregory Feldman
,
Robert Walker
,
Jean Brooks
,
Rashmi Mehta
,
Glenn D Crater
Publication date:
2012-12-01
Journal:
Pulmonary pharmacology & therapeutics
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
cGMP: Generators, Effectors and Therapeutic Implications Conference
Author and article information
Journal
DOI::
10.1016/j.pupt.2012.08.007
PubMed ID::
22955035
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,529
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.i.d. in asthma patients: a 12-week pilot study
Authors:
Claudio Terzano
CONSISTENCY OF DOSE DELIVERY OF FLUTICASONE FUROATE (FF)/UMECLIDINIUM (UMEC)/VILANTEROL (VI) ACROSS PATIENT RELEVANT INHALATION FLOW RATES FROM A DRY-POWDER INHALER (DPI)
Authors:
David Prime
,
Melanie Hamilton
,
Oonagh Patmore
Safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat inhaled doses of umeclidinium in healthy subjects: two randomized studies
Authors:
Marjorie A Cahn
,
R Tal-Singer
,
IJ Pouliquen
See all similar
Cited by
15
The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers
Authors:
Andrew Grant
,
Richard Walker
,
Melanie Hamilton
…
Positioning new pharmacotherapies for COPD
Authors:
Igor Z. Barjaktarevic
,
Anthony Arredondo
,
Christopher B Cooper
Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm
Authors:
John D Blakey
,
Kerry Woolnough
,
Jodie Fellows
…
See all cited by
Version 1
- Current
Version 1